Dr. Stuart A. Harlin, MD

Dr. Harlin practices at Memorial Hermann Katy Hospital - HOPD in Katy, Texas.

Dr. Harlin's NPI, 1568435618, was assigned on February 9, 2006. Dr. Harlin graduated from UT Southwestern Medical Center in 1987. Dr. Harlin's Florida license number on file is ME78858.

Dr. Harlin's primary practice is Memorial Hermann Katy Hospital - HOPD, at 23920 Katy Freeway Suite 120, Katy, TX 77494.

Dr. Harlin's primary practice is Memorial Hermann Katy Hospital - HOPD in Katy, Texas. Dr. Harlin is also affiliated with Memorial Hermann Katy Hospital. The medical group on file is UT Physicians. Dmand AI also links Dr. Harlin to 4 more hospitals, 3 group practices and clinics, 2 medical groups and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Harlin practices, 10 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Harlin's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Harlin is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Harlin's licenses on file in 3 states: Florida, Texas and Mississippi.

Dmand AI lists aortic atherosclerois, arterial blot clot /embolism, carotid revascularization, chronic skin ulcer, deep vein thrombosis (DVT), heart device and aorta surgery, leg revascularization and peripheral vascular disease among the conditions Dr. Harlin treats.

CMS data shows 1,129 Medicare services from Dr. Harlin across 25 procedure codes in 2024, for 325 Medicare patients. Medicare paid $117,773 for them.

CMS counts 325 Medicare patients who saw Dr. Harlin in 2024. The largest group is 65 to 74, with 144 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 3.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Harlin's median patient age at 70, with 45% women.

In 2024, Dr. Harlin wrote 780 Medicare Part D claims for 216 patients. 78% of them were for generic drugs. CMS names the drug for 734 of them, across 11 drugs with 11 or more claims each, at $158,067 in total drug cost. In 2023, CMS named 799 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Harlin for performance year 2024, reported as part of a group. Dr. Harlin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 22 procedures of leg revascularization (restoring blood flow) by Dr. Harlin, more than 82% of the clinicians it reports for that procedure.

Spinal fusion: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 17 papers to Dr. Harlin, published from 2003 to 2023. 2023 was the busiest year, with 3. The most frequent topics are Endovascular Procedures, Stents and Aortic Aneurysm. Dr. Harlin has published most often in J Vasc Surg. Dr. Harlin's most frequent co-authors are George Vasilios Letsou, MD, Gordon Hunter Martin, MD and Hazim J. Safi, MD.

Dmand AI links Dr. Harlin to 6 clinical trials. 2 are still active or recruiting. Conditions studied include Aortic Aneurysm, Abdominal, Aortic Aneurysm and Arteriovenous Fistula. Endologix sponsors the most, 2.

CMS Open Payments shows 464 general payments to Dr. Harlin from 46 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 46% of the total. BTG International, Inc. paid the most, $43,868.

Dmand AI lists 2 awards for Dr. Harlin, most recently CMS Stage 1 2012 in 2011.

Dr. Harlin graduated from UT Southwestern Medical Center in 1987. Dr. Harlin is a member of ACS and SVS.

Dr. Harlin is in network with 23 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 14. Check the plan with the practice before a visit.